Medication info

Light Ezetimibe Tablet 10 mg (Ezetimibe)

Prescription medicationTabletExpired
Ingredient · strength
Ezetimibe›10mg / 1 tablet
Manufacturer / importer
Light PharmTech Co., Ltd.
Appearance
White to nearly white oblong tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Expired

MFDS item code 201906689 · Approved 2019.09.24

This product's status changed to Expired on 2024.09.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
Who uses it
Adults
Adult dosage
A standard cholesterol-lowering diet should be continued during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, with or without food. When used concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), start this medicine at the recommended initial dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, use this medicine concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is used concomitantly with fenofibrate (in patients with mixed dyslipidemia), administer with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). No dose adjustment is necessary in patients with renal impairment. No dose adjustment is necessary in elderly patients. Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Drug Interactions).

Ingredients

Manufacturer
Light PharmTech Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia

  • Primary hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • homozygous familial sitosterolemia
  • hypercholesterolemia
  • dyslipidemia
View approved original text

This medicine helps lower total cholesterol, LDL cholesterol, and apolipoprotein B levels in patients with primary hypercholesterolemia. Additionally, it is used as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and non-HDL cholesterol levels in patients with mixed dyslipidemia. For patients with homozygous familial hypercholesterolemia, it is administered in combination with other treatments or along with statins when other therapies are not effective. It is also used as a dietary adjunct to reduce sitosterol and campesterol levels in patients with homozygous sitosterolemia. This medicine is used alongside an appropriate diet, and it is recommended for patients who do not respond adequately to diet or non-pharmacological treatments. The lipid levels should be closely monitored according to the patient's condition, and it may be combined with treatment for other underlying conditions if necessary. Therefore, this medicine is used to improve hypercholesterolemia and sitosterolemia.

Dosage and Administration

Adult dosage

A standard cholesterol-lowering diet should be continued during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, with or without food. When used concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), start this medicine at the recommended initial dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, use this medicine concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is used concomitantly with fenofibrate (in patients with mixed dyslipidemia), administer with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). No dose adjustment is necessary in patients with renal impairment. No dose adjustment is necessary in elderly patients. Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Drug Interactions).

Precautions

This medicine should not be used in patients with hypersensitivity to its components. Patients with active liver disease or persistent elevated liver enzymes should not take this medicine in conjunction with certain lipid-lowering agents. Pregnant or breastfeeding women should use caution, as co-administration with certain lipid-lowering medications is prohibited. Patients with severely impaired liver function, gallbladder disease, or severe kidney dysfunction should avoid taking this medicine along with certain lipid-lowering agents. Patients with hereditary metabolic disorders like lactose intolerance should also not take this medicine. Patients with severe liver dysfunction may experience increased concentrations of this medicine, leading to unexpected side effects, so it is not recommended. This medicine is generally safe, but side effects such as headache, abdominal pain, diarrhea, fatigue, and muscle pain may occur. In particular, if taken with certain lipid-lowering agents, liver enzyme levels may rise, requiring regular liver function tests. Symptoms like muscle pain or weakness should be reported to a doctor immediately, and in severe cases, drug use should be discontinued. Patients with reduced kidney function can use this medicine, but caution is needed even though no dosage adjustments are required. This medicine can interact with other medications, so it should be discussed with a doctor, especially if the patient is taking cholestyramine, fibrate drugs, anticoagulants, or cyclosporine. Women who are pregnant or may become pregnant should use this medicine cautiously, as it may affect the fetus. Nursing mothers should decide on the use of this medicine based on weighing the risks to the infant against the benefits of the medicine. The use of this medicine is not recommended for children under 6 years of age, but a similar safety profile has been reported for children aged 6 years and older and adolescents. Older adults can also use this medicine, but some patients may respond more sensitively, so caution is needed. There is no specific treatment for overdose, and standard care should be provided based on symptoms. This medicine should be kept out of reach of children, and it is advisable not to store it in a changed container.

Side effects

  • Fatigue
  • abdominal pain
  • diarrhea
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • chest pain
Show 57 more
  • dizziness
  • headache
  • constipation
  • bloating
  • nausea
  • elevated AST
  • elevated ALT
  • myalgia
  • myopathy
  • rhabdomyolysis
  • hepatitis
  • thrombocytopenia
  • pancreatitis
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • chest discomfort
  • chest unease
  • edema
  • weakness
  • generalized edema
  • diabetic neuropathy
  • tremors
  • upper abdominal pain
  • vomiting
  • gastritis
  • xerostomia
  • epigastric discomfort
  • belching
  • gastrointestinal disturbance
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • sputum
  • nasal discharge
  • limb pain
  • diabetes
  • hypoglycemia
  • anemia
  • splenomegaly
  • urticaria
  • hyperhidrosis
  • rash
  • pruritus
  • upper respiratory infection
  • conjunctival injection
  • renal failure
  • abnormal liver function
  • increased serum creatinine
  • increased blood pressure
  • elevated serum urea
  • increased serum creatine phosphokinase
  • abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine is sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to store at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White to nearly white oblong tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.